Schadt Eric
SEC CIK 1873468 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp. | Pres, Chief R, D Off, Dir | 243.4K | $192.0K | $412.2K | 9 | 2021-10-25 | 2022-05-20 |
Most active insiders at WGS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meister Keith A. | Dir, 10% | $74.03M | — |
| 2 | Casdin Capital, LLC | Dir, 10% | $32.57M | — |
| 3 | Stueland Katherine | CEO, Dir | — | $12.90M |
| 4 | RUCH JOSHUA | Dir | — | $6.09M |
| 5 | Feeley Kevin | CFO | — | $4.07M |
| 6 | Dechairo Bryan | COO | — | $850.6K |
| 7 | Fuchs Thomas | Dir | — | — |
| 8 | Leproust Emily M. | Dir | — | — |
| 9 | Ryan Jason | Dir | — | — |
| 10 | Casdin Eli | Dir, 10% | — | — |
Schadt Eric made no open-market trades at WGS in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-24 | 2022-05-20 | WGS | GeneDx Holdings Corp. | Schadt Eric | Pres, Chief R, D Off, Dir | P - Purchase | $1.92 | +100.0K | 243.4K | +70% | +$192.0K | |
| 2022-05-02 | 2022-04-28 | WGS | GeneDx Holdings Corp. | Schadt Eric | Pres, Chief R, D Off, Dir | S - Sale | $2.18 | -35.9K | 143.4K | -20% | -$78.3K | |
| D | 2022-04-27 | 2022-04-25 | WGS | GeneDx Holdings Corp. | Schadt Eric | CEO, Dir | M - OptEx | — | +78.8K | 179.3K | +78% | — |
| 2022-02-02 | 2022-01-28 | WGS | GeneDx Holdings Corp. | Schadt Eric | CEO, Dir | S - Sale | $2.84 | -29.1K | 100.5K | -22% | -$82.6K | |
| D | 2022-01-27 | 2022-01-25 | WGS | GeneDx Holdings Corp. | Schadt Eric | CEO, Dir | M - OptEx | — | +78.8K | 129.6K | +155% | — |
| 2021-12-03 | 2021-12-01 | WGS | GeneDx Holdings Corp. | Schadt Eric | CEO, Dir | F - Tax | $5.52 | -5,452 | 50.8K | -10% | -$30.1K | |
| 2021-12-03 | 2021-12-01 | WGS | GeneDx Holdings Corp. | Schadt Eric | CEO, Dir | A - Grant | $6.05 | +10.7K | 56.2K | +24% | +$64.9K | |
| D | 2021-11-02 | 2021-10-25 | WGS | GeneDx Holdings Corp. | Schadt Eric | CEO, Dir | S - Sale+OE | $7.54 | -33.3K | 45.5K | -42% | -$251.3K |
| D | 2021-11-02 | 2021-10-25 | WGS | GeneDx Holdings Corp. | Schadt Eric | CEO, Dir | M - OptEx | — | +78.8K | 78.8K | New | — |
Purchase Sale Sale after option exercise All abbreviations